Romanian Raids On Boehringer Result In Eight-Figure Fine For COPD Market Abuse
‘Intensive Promotion Strategy’ Influenced Doctors To Prescribe Follow-Up Spiolto Respimat
Boehringer Ingelheim “made it more difficult” for doctors to prescribe generic versions of its Spiriva (tiotropium) inhalers, Romania’s Competition Council has found, as it levied a fine of more than $25m on the German originator.
